Cover Image

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review

BackgroundEvidence of the preventive and therapeutic effects of enalapril on cardiotoxicity caused by chemotherapy needs to be further confirmed and updated.MethodsWe performed a systematic review of studies from electronic databases that were searched from inception to January 29, 2019, and include...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yili Zhang (Author), Junjie Liu (Author), Yuan Li (Author), Nannan Tan (Author), Kangjia Du (Author), Huihui Zhao (Author), Juan Wang (Author), Jian Zhang (Author), Wei Wang (Author), Yong Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
by: Kangjia Du, et al.
Published: (2022)

An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
by: Sicong Xie, et al.
Published: (2024)

The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
by: Marwa Tantawy, et al.
Published: (2021)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
by: Junqi Huang, et al.
Published: (2022)

Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis
by: Lili Yang, et al.
Published: (2024)

Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines
by: Xiaomeng Liu, et al.
Published: (2024)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014)

Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
by: Varen Zhi Zheng Tan, et al.
Published: (2021)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023)

Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
by: Shuxu Du, et al.
Published: (2018)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
by: Peng Zhou, et al.
Published: (2022)

Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network
by: Guoxing Wan, et al.
Published: (2021)

Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity
by: Weili Li, et al.
Published: (2021)

Reliability of Metformin's protective effects against doxorubicin-induced cardiotoxicity: a meta-analysis of animal studies
by: Ming-Li Sun, et al.
Published: (2024)

Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
by: Panxia Wang, et al.
Published: (2021)

Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update
by: Mingli Sun, et al.
Published: (2024)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022)

Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats
by: Lijuan Zhao, et al.
Published: (2021)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020)

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
by: Wei Wang, et al.
Published: (2020)

Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products
by: Yuanying Yang, et al.
Published: (2021)

Mass Production of Rg1-Loaded Small Extracellular Vesicles Using a 3D Bioreactor System for Enhanced Cardioprotective Efficacy of Doxorubicin-Induced Cardiotoxicity
by: Yunfeng Di, et al.
Published: (2024)

The first description of mucous membrane pemphigoid induced by enalapril maleate: a case report
by: Yihang Xie, et al.
Published: (2024)

Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity
by: Ni Zhou, et al.
Published: (2023)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
by: Makoto Kodama, et al.
Published: (2011)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
by: Lin Li, et al.
Published: (2020)

Mechanism of Chinese Medicine Herbs Effects on Chronic Heart Failure Based on Metabolic Profiling
by: Kuo Gao, et al.
Published: (2017)

DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway
by: Danqi Chang, et al.
Published: (2019)

Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
by: Yuping Wu, et al.
Published: (2018)

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
by: Jing Lu, et al.
Published: (2019)

Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies
by: Nivesh K. Mittal, et al.
Published: (2018)

The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice
by: Haozhen Shao, et al.
Published: (2020)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
by: ZiYan Yang, et al.
Published: (2021)

Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1/NOX4/Reactive Oxygen Species/MAPK Pathway
by: Hui Zheng, et al.
Published: (2022)

Correlation of Speckle-Tracking Echocardiography with Traditional Biomarkers in Predicting Cardiotoxicity among Pediatric Hemato-Oncology Patients: A Comprehensive Evaluation of Anthracycline Dosages and Treatment Protocols
by: Andrada Mara Ardelean, et al.
Published: (2023)